References
- National Cancer Institute. Cancer Trends Progress Report - 2005 Update. Available online at: http://progressreport.cancer.gov. Last accessed March 6, 2008.
- Nattinger AB, Hoffman RG, Kneusel RT, et al. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148–1153.
- King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180:299–304.
- Vicini FA, Antonucci JV, Goldstein N, et al. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: A molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys. 2007;68:341–6.
- Dickler A, Kirk M, Choo J, et al. Cosmetic outcome and incidence of infection with the mammosite breast brachytherapy applicator. Breast. 2005;11:306–310.
- Benitez PR, Keisch ME, Vicini F, et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–462.
- Keisch M, Vicini F, Kuske R, et al. Two-year outcome with the MammoSite breast brachytherapy applicator: Factors associated with optimal cosmetic outcome when performing partial breast irradiation. Int J Radiat Oncol Biol Phys. 2003;57:S311.
- Dickler A, Kirk M, Seif N, et al. A dosimetric comparison of MammoSite HDR brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007;6:164–16.
- Dickler A, Kirk M, Coon A, et al. A Dosimetric Comparison of Xoft Axxent Electronic Brachytherapy and Ir-192 HDR Brachytherapy in the Treatment of Endometrial Cancer. Proceedings of the 2008 American Brachytherapy Society Meeting.